MASON, Andrew L

5 records totalling $2,554,348.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

MASON, Andrew L $768,058.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2014-2015
Canada

Translational studies to test potential therapies for patients with primary biliary cirrhosis

Mason, Andrew L $703,800.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2018-2019
Canada

Pilot study of emtricitabine, tenofovir alafenamide and raltegravir for patients with primary biliary cholangitis

MASON, Andrew L $506,269.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada

Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis

MASON, Andrew L $426,221.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2011-2012
Canada

Isolation of a novel human retrovirus associated with primary biliary cirrhosis and fulfillment of koch's postulates in vitro

Mason, Andrew L $150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2020-2021
Canada

The specific objective of this funding opportunity is: To harness the power of new technologies and interventions to prevent the onset of cancer and/or reduce its severity though early detection wh...